Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent).
AUTOR(ES)
Barlough, J E
RESUMO
A Thoroughbred filly that developed clinical signs of equine granulocytic ehrlichiosis following inoculation with the human granulocytotropic ehrlichia was shown to be resistant to challenge with Ehrlichia equi, a closely related agent. This result further substantiates the close and potentially conspecific relationship between these two granulocytotropic ehrlichiae.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=228702Documentos Relacionados
- Inter- and Intralaboratory Comparison of Ehrlichia equi and Human Granulocytic Ehrlichiosis (HGE) Agent Strains for Serodiagnosis of HGE by the Immunofluorescent-Antibody Test
- Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia.
- Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.
- Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).
- Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses.
